Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by lovingstocks23on Apr 01, 2021 5:39pm
213 Views
Post# 32925312

RE:Financials Out

RE:Financials OutWhat you mean nothing good ? They are going to move into mostly edibles and other high profit margin products. Their adjusted ebitda is a lot better than last year. They got $1M in rev which is more than I expected considering prices for cannabis are going down. They're very close to getting orders from Quebec. They're waiting for final approval to start increasing production of edibles with their 3 new rooms. I think they're in line with Fundamental Research' expectations. The path to profitability could not be any more clear than this. They laid out their entire plan. It's very transparent. Website is fixed. Only thing left is improving edibles supply and pump out the cigs. This is the first time I'm actually seeing the light at the end of the tunnel.
<< Previous
Bullboard Posts
Next >>